01 Transition Toward Automated and Closed System Cryopreservation Technologies The cell cryopreservation market is experiencing a growing trend toward the adoption of automated and closed-system cryopreservation technologies that enhance process control, reproducibility, and contamination prevention. Traditional manual freezing methods are being replaced by fully automated cryogenic systems integrated with real-time monitoring and robotic handling to ensure consistent temperature regulation and standardized cell storage conditions. For instance, in February 2025, Cytiva launched its next-generation VIA Freeze system equipped with digital sensors and data logging capabilities to optimize cell freezing curves and improve viability outcomes. This shift toward automation and closed systems improved scalability, reduced human error, and supported compliance with good manufacturing practice (GMP) standards in cell therapy manufacturing and biobanking applications.
02 Rising Focus on Development of Novel Cryoprotectants and Ice-Free Preservation Methods The emerging trend in the cell cryopreservation market is the development of novel cryoprotectant formulations and ice-free preservation techniques aimed at minimizing cellular damage during freezing and thawing. Conventional agents such as dimethyl sulfoxide (DMSO) are associated with cytotoxicity and post-thaw cell dysfunction, driving research toward non-toxic and biocompatible alternatives. In June 2025, researchers at the University of California developed a polymer-based cryoprotectant capable of preventing intracellular ice formation and maintaining over 90% cell viability after thawing. Additionally, advancements in vitrification and nano-engineered cooling systems are enabling faster cooling rates and improved structural integrity of preserved cells. This growing emphasis on safer, more efficient cryopreservation solutions is transforming long-term cell storage and expanding applications in regenerative medicine, stem cell banking, and reproductive biology.
June 2026 Azenta Life Sciences expanded its global biorepository network by opening a new cryogenic storage facility to strengthen cell preservation and biobanking services for the life sciences industry.
October 2025 BioLife Solutions launched an advanced cryopreservation media designed to improve post-thaw cell viability and support the storage of cell and gene therapies.
May 2025 Thermo Fisher Scientific expanded its cold storage and cryopreservation portfolio with new automated cryogenic storage solutions for biopharmaceutical and clinical research applications.